Clariant Invests in New Packaging Plant in India

Clariant announced on Dec. 1, 2015 that it is investing CHF 10 million in a new packaging manufacturing plant in Cuddalore, India. The plant will manufacture Clariant’s moisture-control products to support the growing pharmaceutical packaging market in India.

The company recognizes India’s position as the largest generic-drug producer. Ketan Premani, head of Clariant Healthcare Packaging Sales in India, commented in a press release this makes India a key market for Clariant’s desiccant products. The new Cuddalore plant will serve branded and generic drug companies operating in India as well as domestic players.

Clariant Healthcare Packaging, a member of Business Unit Masterbatches, manufactures a range of controlled atmosphere packaging solutions including pharmaceutical desiccants, equilibrium sorbents, adsorbent polymers, oxygen scavengers, and pharmaceutical closures and containers. The Cuddalore plant will initially produce desiccant canisters and packets, which are inserted into pharmaceutical packaging to control moisture and protect the stability of the medicine during shelf life. The desiccant production area will be clean room Class 100,000 and certified ISO 8. It will be compliant with all relevant cGMP and US FDA standards.